Bentham Science Logo

Track Your Manuscript:


Current Pharmaceutical Design

Volume 26, 46 Issues, 2020
ISSN: 1873-4286 (Online)
ISSN: 1381-6128 (Print)
This journal supports open access
Order Your Article Before PrintSubscribe to this Journal

In the current pandemic scenario, publication process of all articles related to Coronavirus will be expedited, for timely publication of much needed research

Contents

Current Pharmaceutical Design, Volume 13 - Number 30





Susceptibility of Periodontopathogenic and Cariogenic Bacteria to Defensins and Potential Therapeutic Use of Defensins in Oral Diseases

, 13(30): 3084 - 3095

Hitoshi Komatsuzawa, Kazuhisa Ouhara, Toshihisa Kawai, Sakuo Yamada, Tamaki Fujiwara, Hideki Shiba, Hidemi Kurihara, Martin A. Taubman and Motoyuki Sugai


DOI: 10.2174/138161207782110426




Defensin Participation in Innate and Adaptive Immunity

, 13(30): 3131 - 3139

De Yang, Zhen-hua Liu, Poonam Tewary, Qian Chen, Gonzalo de la Rosa and Joost J. Oppenheim


DOI: 10.2174/138161207782110453





Editor-in-Chief

William A. Banks
(45093 citations)
Seattle VA Puget Sound Health Care System
Room 810C, Building 1
1660 S. Columbian Way
Seattle, WA 98108
(USA)

Biography
View Full Editorial Board

Executive Editor

Atta-ur-Rahman, FRS
(29381 citations)
Honorary Life Fellow
Kings College
University of Cambridge
Cambridge
(UK)
Biography

Nobel Laureate on Editorial Board

Andrew V. Schally
(USA)

Journal History

Current Pharmaceutical Design was introduced in 1995 with the assistance of Dr. William A. Banks, who is the current Editor-in-Chief serving since 1995.
Scopus CiteScore Metrics: 2.32

Advertisement

STATISTICS AND DATA PRESENTATIONCovid Resource CenterCoronaviruses-JOIN-EDITORIAL-BOARD

Related Journals

Related eBooks

eBooks Catalog